Search Results - "BACHERT, Claus"

Refine Results
  1. 1

    Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis by Bachert, Claus, MD, PhD, Zhang, Luo, MD, Gevaert, Phillippe, MD

    Published in Journal of allergy and clinical immunology (01-12-2015)
    “…Chronic rhinosinusitis (CRS) affects more than 10% of the population in the United States and Europe. Recent findings point to a considerable variation of…”
    Get full text
    Journal Article
  2. 2

    Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials by Gevaert, Philippe, Omachi, Theodore A., Corren, Jonathan, Mullol, Joaquim, Han, Joseph, Lee, Stella E., Kaufman, Derrick, Ligueros-Saylan, Monica, Howard, Monet, Zhu, Rui, Owen, Ryan, Wong, Kit, Islam, Lutaf, Bachert, Claus

    Published in Journal of allergy and clinical immunology (01-09-2020)
    “…Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by IgE hyperproduction and eosinophilic inflammation. The anti-IgE antibody, omalizumab, has…”
    Get full text
    Journal Article
  3. 3

    Pathogenesis of chronic rhinosinusitis: Inflammation by Van Crombruggen, Koen, PhD, Zhang, Nan, MD, Gevaert, Philippe, MD, Tomassen, Peter, MD, Bachert, Claus, MD, PhD

    Published in Journal of allergy and clinical immunology (01-10-2011)
    “…Chronic rhinosinusitis (CRS) is a heterogeneous group of inflammatory diseases of the nasal and paranasal cavities either accompanied by polyp formation…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Real‐world benefits of allergen immunotherapy for birch pollen‐associated allergic rhinitis and asthma by Wahn, Ulrich, Bachert, Claus, Heinrich, Joachim, Richter, Hartmut, Zielen, Stefan

    Published in Allergy (Copenhagen) (01-03-2019)
    “…Background Real‐world evidence is sparse on the benefits of allergen immunotherapy [AIT; subcutaneous/sublingual immunotherapy (SCIT/SLIT)], the only…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Type 2 inflammation in chronic rhinosinusitis without nasal polyps: Another relevant endotype by Delemarre, Tim, Holtappels, Gabriele, De Ruyck, Natalie, Zhang, Nan, Nauwynck, Hans, Bachert, Claus, Gevaert, Elien

    Published in Journal of allergy and clinical immunology (01-08-2020)
    “…Chronic rhinosinusitis without nasal polyps (CRSsNP) is mainly considered a type 1 mediated disease. The role and clinical significance of type 2 immune…”
    Get full text
    Journal Article
  10. 10

    Endotypes of chronic rhinosinusitis: Impact on management by Cardell, Lars-Olaf, Stjärne, Pär, Jonstam, Karin, Bachert, Claus

    Published in Journal of allergy and clinical immunology (01-03-2020)
    “…Following the trend in asthma, endotypes for chronic rhinosinusitis with nasal polyps have been established, with type 2 immune reactions representing >80% of…”
    Get full text
    Journal Article
  11. 11

    Evidence-based management of acute rhinosinusitis with herbal products by Bachert, Claus

    Published in Clinical phytoscience (07-12-2020)
    “…Background The overuse of antibiotics for unjustified indications such as the management of acute uncomplicated rhinosinusitis has contributed to the emergence…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Phenotypes and Emerging Endotypes of Chronic Rhinosinusitis by Bachert, Claus, MD, PhD, Akdis, Cezmi A., MD

    “…Chronic rhinosinusitis can be differentiated into several phenotypes based on clinical criteria; however, these phenotypes do not teach us much about the…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Sensitization patterns and minimum screening panels for aeroallergens in self-reported allergic rhinitis in China by Lou, Hongfei, Ma, Siyuan, Zhao, Yan, Cao, Feifei, He, Fei, Liu, Zhongyan, Bousquet, Jean, Wang, Chengshuo, Zhang, Luo, Bachert, Claus

    Published in Scientific reports (24-08-2017)
    “…Optimization of skin prick test (SPT) panels, especially in view of significant differences in sensitizations patterns within different geographical areas, is…”
    Get full text
    Journal Article
  18. 18

    Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation by Krysko, Dmitri V, Agostinis, Patrizia, Krysko, Olga, Garg, Abhishek D, Bachert, Claus, Lambrecht, Bart N, Vandenabeele, Peter

    Published in Trends in immunology (01-04-2011)
    “…Cell death and injury often lead to release or exposure of intracellular molecules called damage-associated molecular patterns (DAMPs) or cell death-associated…”
    Get full text
    Journal Article
  19. 19

    Novel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell death by Turubanova, Victoria D., Mishchenko, Tatiana A., Balalaeva, Irina V., Efimova, Iuliia, Peskova, Nina N., Klapshina, Larisa G., Lermontova, Svetlana A., Bachert, Claus, Krysko, Olga, Vedunova, Maria V., Krysko, Dmitri V.

    Published in Scientific reports (30-03-2021)
    “…The immunogenicity of dying cancer cells determines the efficacy of anti-cancer therapy. Photodynamic therapy (PDT) can induce immunogenic cell death (ICD),…”
    Get full text
    Journal Article
  20. 20

    Endoscopic Sinus Surgery for Type‐2 CRS wNP: An Endotype‐Based Retrospective Study by Alsharif, Saeed, Jonstam, Karin, van Zele, Thibaut, Gevaert, Philippe, Holtappels, Gabriele, Bachert, Claus

    Published in The Laryngoscope (01-06-2019)
    “…Objectives Nasal polyps are often characterized by type 2 inflammation and disease recurrence. We developed a new surgical technique, referred to as reboot…”
    Get full text
    Journal Article